Erythema gyratum repens
| Erythema gyratum repens | |
|---|---|
| Synonyms | EGR |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | N/A |
| Complications | N/A |
| Onset | N/A |
| Duration | N/A |
| Types | N/A |
| Causes | N/A |
| Risks | N/A |
| Diagnosis | N/A |
| Differential diagnosis | N/A |
| Prevention | N/A |
| Treatment | N/A |
| Medication | N/A |
| Prognosis | N/A |
| Frequency | N/A |
| Deaths | N/A |
Erythema gyratum repens (EGR) is a rare paraneoplastic syndrome characterized by distinctive skin changes. It is often associated with underlying malignancy, particularly lung cancer.
Presentation[edit]
Erythema gyratum repens is marked by rapidly evolving erythematous rashes that form concentric, wood-grain-like patterns on the skin. These lesions are typically pruritic and can cover large areas of the body. The rash is known for its unique appearance and rapid progression.
Associated Conditions[edit]
EGR is most commonly associated with lung cancer, but it can also be linked to other types of cancer such as breast cancer, esophageal cancer, and stomach cancer. In some cases, EGR may precede the diagnosis of the underlying malignancy, making it an important clinical sign for early detection.
Diagnosis[edit]
The diagnosis of erythema gyratum repens is primarily clinical, based on the characteristic appearance of the rash. A thorough medical history and physical examination are essential. Skin biopsy may be performed to rule out other conditions. Additionally, screening for underlying malignancies is crucial once EGR is suspected.
Treatment[edit]
The primary approach to managing erythema gyratum repens involves treating the underlying malignancy. Successful treatment of the associated cancer often leads to resolution of the skin lesions. Symptomatic treatment for the rash may include topical corticosteroids and antihistamines to alleviate itching.
Prognosis[edit]
The prognosis of erythema gyratum repens largely depends on the underlying malignancy. Early detection and treatment of the associated cancer can improve outcomes. The skin manifestations typically resolve once the malignancy is addressed.
See also[edit]
References[edit]
External links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian